Fox Business: AXIM Biotech Featured in Article on New Product Patent

AXIM Biotechnologies (OTC:AXIM) was featured in an article by Fox Business covering the market potential for their new clinical development product patent.

“AXIM Biotech (AXIM), a world leader in hemp cannabinoid research and development, is one of those companies. It recently received patent approval for the use of all cannabinoids – chemical compounds found in marijuana plants – in its controlled-release chewing gum.”